Relationships among MTHFR a1298c gene polymorphisms and methylation status of dact1 gene in transitional cell carcinomas

Asian Pacific Journal of Cancer Prevention

Volumn 13, Issue 10, 2012, Pages 5069-5074

  Cheng, Huan ^a   Lu, Meng ^a   Mao, Li Jun ^a   Wang, Jun Qi ^a   Li, Wang ^a   Wen, Ru Min ^a   Chen, Jia Cun ^a  

^a XUZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Dact1; Epidemiology; Folate; Methylation; MTHFR; Transitional cell carcinoma

Indexed keywords

EID: 84874004375     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2012.13.10.5069     Document Type: Article

References (40)

1. Axume J, Smith SS, Pogribny IP, et al (2007).The MTHFR 677TT genotype and folate intake interact to lower global leukocyte DNA methylation in young Mexican American women. Nutr Res, 27, 1365-7.
2. Batra V, Mishra KP (2007). Modulation of DNA methyltransferase profile by methyl donor starvation followed by gamma irradiation. Mol Cell Biochem, 294, 181-7.
3. Brait M, Sidransky D (2011). Cancer epigenetics: above and beyond. Toxicol Mech Methods, 21, 275-88.
4. Cellarier E, Durando X, Vasson MP, et al (2003). Methionine dependency and cancer treatment. Cancer Treat Rev, 29, 489-99.
5. Chalitchagorn K, Shuangshoti S, Hourpai N, et al (2004). Distinctive pattern of LINE-1 methylation level in normal tissues and the association with carcinogenesis. Oncogene, 23, 8841-6.
6. Cheyette BN, Waxman JS, Miller JR, et al (2002). Dapper, a Dishevelled-associated antagonist of beta-catenin and JNK signaling,is required for notochord formation. Dev Cell, 2, 449-61.
7. Choi IS, Estecio MR, Nagano Y, et al (2007). Hypomethylation of LINE-1 and Alu in well-differentiated neuroendocrine tumors (pancreatic endocrine tumors and carcinoid tumors). Mod Pathol, 20, 802-10.
8. Eze OP, Starker LF, Carling T (2011).The role of epigenetic alterations in papillary thyroid carcinogenesis. J Thyroid Res, 2011, 895470.
9. Fang JY, Lu R, Mikovits JA, et al (2006). Regulation of hMSH2 and hMLH1 expression in the human colon cancer cell line SW1116 by DNA methyltransferase 1. Cancer Lett, 233, 124-30.
10. Feinberg AP (2004). The epigenetics of cancer etiology. Semin Cancer Biol, 14, 427-32.
11. Fraga MF, Agrelo R, Esteller M (2007). Cross-talk between aging and cancer: the epigenetic language. Ann N Y Acad Sci, 1100, 60-74.
12. Friso S, Girelli D, Trabetti E, et al (2005). The MTHFR 1298A>C polymorphism and genomic DNA methylation in human lymphocytes. Cancer Epidemiol Biomarkers Prev, 14, 938-43.
13. Gonzalo V, Castellvi-Bel S, Balaguer F, et al (2008). Epigenetics of cancer. Gastroenterol Hepatol, 31, 37-45.
14. Hansen MF, Cavenee WK (1988). Tumor suppressors: recessive mutations that lead to cancer. Cell, 53, 173-4.
15. Hilton JL, Geisler JP, Rathe JA, et al (2002). Inactivation of BRCA1 and BRCA2 in ovarian cancer. J Natl Cancer Inst, 94, 1396-400.
16. Huang J, Vieira A (2006). DNA methylation, riboswitches, and transcription factor activity: fundamental mechanisms of gene-nutrient interactions involving vitamins. Mol Biol Rep, 33, 253-6.
17. Hunter T (1997). Oncoprotein networks. Cell, 88, 333-46.
18. Jakubowska A, Gronwald J, Menkiszak J, et al (2007). Methylenetetrahydrofolate reductase polymorphisms modify BRCA1-associated breast and ovarian cancer risks. Breast Cancer Res Treat, 104, 299-308.
19. Jones PA, Baylin SB (2002). The fundamental role of epigenetic events in cancer. Nat Rev Genet, 3, 415-28.
20. Jones PA, Baylin SB (2007). The epigenomics of cancer. Cell, 128, 683-92.
21. Katoh M (2003). Identification and characterization of human DAPPER1 and DAPPER2 genes in silico. Int J Oncol, 22, 907-13.
22. Lin J, Spitz MR, Wang Y, et al (2004). Polymorphisms of folate metabolic genes and susceptibility to bladder cancer: a case-control study. Carcinogenesis, 25, 1639-47.
23. Liu L, Li Y, Tollefsbol TO (2008).Gene-environment interactions and epigenetic basis of human diseases. Curr Issues Mol Biol, 10, 25-36.
24. Ma J, Stampfer MJ, Giovannucci E, et al (1997). Methylenetetrahydrofolate reductase polymorphism, dietary interactions, and risk of colorectal cancer. Cancer Res, 57, 1098-102.
25. Marsit CJ, Houseman EA, Christensen BC, et al (2010) . Identification of methylated genes associated with aggressive bladder cancer. PLoS One, 5, e12334.
26. Milutinovic S, D'Alessio AC, Detich N, et al (2007). Valproate induces widespread epigenetic reprogramming which involves demethylation of specific genes. Carcinogenesis, 28, 560-71.
27. Nicholson L, Singh GK, Osterwalder T, et al (2008). Spatial and temporal control of gene expression in Drosophila using the inducible GeneSwitch GAL4 system. I. Screen for larval nervous system drivers. Genetics, 178, 215-34.
28. Oyama K, Kawakami K, Maeda K, et al (2004). The association between methylenetetrahydrofolate reductase polymorphism and promoter methylation in proximal colon cancer. Anticancer Res, 24, 649-54.
29. Paige AJ (2003). Redefining tumour suppressor genes: exceptions to the two-hit hypothesis. Cell Mol Life Sci, 60, 2147-63.
30. Safarinejad MR, Shafiei N, Safarinejad S (2011). Genetic susceptibility of methylenetetrahydrofolate reductase (MTHFR) gene C677T, A1298C, and G1793A polymorphisms with risk for bladder transitional cell carcinoma in men. Med Oncol, 28, S398-412.
31. Supic G, Jovic N, Kozomara R, et al (2011). Interaction between the MTHFR C677T polymorphism and alcohol--impact on oral cancer risk and multiple DNA methylation of tumor-related genes. J Dent Res, 90, 65-70.
32. Tada Y, Yokomizo A, Shiota M, et al (2011). Aberrant DNA methylation of T-cell leukemia, homeobox 3 modulates cisplatin sensitivity in bladder cancer. Int J Oncol, 39, 727-33.
33. Vikram R, Sandler CM, Ng CS (2009). Imaging and staging of transitional cell carcinoma: part 1, lower urinary tract. AJR Am J Roentgenol, 192, 1481-7.
34. Wang LD, Guo RF, Fan ZM, et al (2005). Association of methylenetetrahydrofolate reductase and thymidylate synthase promoter polymorphisms with genetic susceptibility to esophageal and cardia cancer in a Chinese high-risk population. Dis Esophagus, 18, 177-84.
35. Weisberg I, Tran P, Christensen B, et al (1998). A second genetic polymorphism in methylenetetrahydrofolate reductase (MTHFR) associated with decreased enzyme activity. Mol Genet Metab, 64, 169-72.
36. Yang CX, Matsuo K, Ito H, et al (2005). Gene-environment interactions between alcohol drinking and the MTHFR C677T polymorphism impact on esophageal cancer risk: results of a case-control study in Japan. Carcinogenesis, 26, 1285-90.
37. Yang ZQ, Zhao Y, Liu Y, et al (2010). Downregulation of HDPR1 is associated with poor prognosis and affects expression levels of p120-catenin and beta-catenin in nonsmall cell lung cancer. Mol Carcinog, 49, 508-19.
38. Yau TO, Chan CY, Chan KL, et al (2005). HDPR1, a novel inhibitor of the WNT/beta-catenin signaling, is frequently downregulated in hepatocellular carcinoma: involve ment of methylation-mediated gene silencing. Oncogene, 24, 1607-14.
39. Zhang FF, Morabia A, Carroll J, et al (2011).Dietary patterns are associated with levels of global genomic DNA methylation in a cancer-free population. J Nutr, 141, 1165-71.
40. Zhu D, Hunter SB, Vertino PM, et al (2011). Overexpression of MBD2 in glioblastoma maintains epigenetic silencing and inhibits the antiangiogenic function of the tumor suppressor gene BAI1. Cancer Res, 71, 5859-70.